SecBot SecBot
144 ·Filed Jun 2, 2026

EVMN

Evommune, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago SEC0001950047-26-005513
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine, small-scale Form 144 filing by a director with no executive role. The sale amount is immaterial relative to both his holdings and the company's market cap. No actionable signal for traders — monitor for any unexpected acceleration of insider selling ahead of upcoming catalysts.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
EVMN ▼ -31.68% at T+60d
NEUTRAL call -31.68% · α vs SPY -34.18% · entry $19.73 → $13.48
Entry = T+0 close
Jun 2, 2026
via day close
T+1d
+4.87%
call +4.87% · α +4.47%
$20.69
settled 5mo ago
T+5d
+3.85%
call +3.85% · α +7.67%
$20.49
settled 5mo ago
T+20d
-34.31%
call -34.31% · α -33.31%
$12.96
settled 4mo ago
T+60d
-31.68%
call -31.68% · α -34.18%
$13.48
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Director David E. Cohen filed a Form 144 notice of intent to sell 9,258 shares of Evommune (EVMN) common stock, with an estimated aggregate market value of approximately $205,250 based on the filing date. This represents a modest portion of his total reported holdings of ~36 million shares and is a routine insider sale by a director, not executive management.

Key Facts

  • Director David E. Cohen filed Form 144 on June 2, 2026, indicating intent to sell 9,258 shares.
  • Estimated aggregate market value of the proposed sale is approximately $205,250.
  • Shares were acquired via pre-IPO purchase (6,056 shares on 6/23/2020) and restricted stock awards (3,202 shares on 5/29/2020).
  • Cohen's total holdings are reported as ~36 million shares, making this sale less than 0.03% of his position.
  • The sale is planned for the open market through Morgan Stanley Smith Barney.
  • Recent insider activity (30d) shows 2 prior sells totaling $740K, consistent with routine portfolio diversification.

Financial Impact

Proposed sale of ~$205K in EVMN common stock, representing a negligible fraction of the director's total holdings and less than 0.03% of the company's $799M market cap.

dilution

Risk Factors

  • Form 144 is only an intent to sell; the transaction may not be executed.
  • If other insiders file similar notices in the coming weeks, it could signal broader insider sentiment.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-005513
Document: 0001950047-26-005513-index.html0001950047-26-005513
Document: 0001950047-26-005513.txt0001950047-26-005513
15 reports for EVMN
Performance horizon
75% Hit rate @ T+60 3 of 4 directional calls Went positive at some point 3 of 5 best @ T+60▲ +41.15%May 28, 2026
Filters
Rows
Reports for EVMN — sortable, filterable
TypeNow
Oct 1, 2026
26d ago
8-K
BULLISH ★ 7/10
$7.21awaiting T+60—$5.13 (−28.85%)
Sep 15, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$9.99awaiting T+60—$5.13 (−48.65%)
Jul 30, 2026
12w ago
8-K
NEUTRAL ★ 5/10
$11.35 $5.10▼ −55.07%▼ −57.53%$5.13 (−54.80%)
Jul 10, 2026
15w ago
Insider Cluster
NEUTRAL ★ 3/10
$12.10 $6.61▼ −45.37%▼ −49.37%$5.13 (−57.60%)
Jun 29, 2026
17w ago
8-K
BEARISH ★ 7/10
$15.05 $9.60▲ +36.21%▲ +40.60%$5.13 (+65.91%)
Jun 24, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$24.13 $9.65▼ −60.01%▼ −63.74%$5.13 (−78.74%)
Jun 3, 2026
20w ago
Insider Cluster
BEARISH ★ 5/10
$20.69 $13.23▲ +36.06%▲ +37.94%$5.13 (+75.21%)
Jun 2, 2026
21w ago
144
NEUTRAL ★ 3/10
$19.73 $13.48▼ −31.68%▼ −34.18%$5.13 (−74.00%)
Jun 1, 2026
21w ago
Insider Cluster
NEUTRAL ★ 3/10
$19.82 $14.11▼ −28.81%▼ −29.93%$5.13 (−74.12%)
May 28, 2026
21w ago
144
BEARISH ★ 5/10
$23.23 $13.67▲ +41.15%▲ +42.34%$5.13 (+77.92%)
Showing 10 of 15

US Market Status

Market Closed — Opens Thu (12h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 2, 2026